Cargando…

APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer’s Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that requires further pathological elucidation to establish effective treatment strategies. We previously showed that amyloid β (Aβ) toxic conformer with a turn at positions 22–23 is essential for forming highly toxic oligomers. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Maki, Takahito, Sawahata, Masahito, Akutsu, Ichiro, Amaike, Shohei, Hiramatsu, Genki, Uta, Daisuke, Izuo, Naotaka, Shimizu, Takahiko, Irie, Kazuhiro, Kume, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654501/
https://www.ncbi.nlm.nih.gov/pubmed/36362046
http://dx.doi.org/10.3390/ijms232113259
_version_ 1784828947754647552
author Maki, Takahito
Sawahata, Masahito
Akutsu, Ichiro
Amaike, Shohei
Hiramatsu, Genki
Uta, Daisuke
Izuo, Naotaka
Shimizu, Takahiko
Irie, Kazuhiro
Kume, Toshiaki
author_facet Maki, Takahito
Sawahata, Masahito
Akutsu, Ichiro
Amaike, Shohei
Hiramatsu, Genki
Uta, Daisuke
Izuo, Naotaka
Shimizu, Takahiko
Irie, Kazuhiro
Kume, Toshiaki
author_sort Maki, Takahito
collection PubMed
description Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that requires further pathological elucidation to establish effective treatment strategies. We previously showed that amyloid β (Aβ) toxic conformer with a turn at positions 22–23 is essential for forming highly toxic oligomers. In the present study, we evaluated phenotypic changes with aging in AD model App(NL-P-F/NL-P-F) (NL-P-F) mice with Swedish mutation (NL), Iberian mutation (F), and mutation (P) overproducing E22P-Aβ, a mimic of toxic conformer utilizing the knock-in technique. Furthermore, the role of the toxic conformer in AD pathology was investigated. NL-P-F mice produced soluble toxic conformers from an early age. They showed impaired synaptic plasticity, glial cell activation, and cognitive decline, followed by the accumulation of Aβ plaques and tau hyperphosphorylation. In addition, the protein expression of hypoxia-inducible factor (HIF)-1α was increased, and gene expression of HIF-3α was decreased in NL-P-F mice. HIF dysregulation due to the production of soluble toxic conformers may be involved in AD pathology in NL-P-F mice. This study could reveal the role of a highly toxic Aβ on AD pathogenesis, thereby contributing to the development of a novel therapeutic strategy targeting the toxic conformer.
format Online
Article
Text
id pubmed-9654501
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96545012022-11-15 APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer’s Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression Maki, Takahito Sawahata, Masahito Akutsu, Ichiro Amaike, Shohei Hiramatsu, Genki Uta, Daisuke Izuo, Naotaka Shimizu, Takahiko Irie, Kazuhiro Kume, Toshiaki Int J Mol Sci Article Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that requires further pathological elucidation to establish effective treatment strategies. We previously showed that amyloid β (Aβ) toxic conformer with a turn at positions 22–23 is essential for forming highly toxic oligomers. In the present study, we evaluated phenotypic changes with aging in AD model App(NL-P-F/NL-P-F) (NL-P-F) mice with Swedish mutation (NL), Iberian mutation (F), and mutation (P) overproducing E22P-Aβ, a mimic of toxic conformer utilizing the knock-in technique. Furthermore, the role of the toxic conformer in AD pathology was investigated. NL-P-F mice produced soluble toxic conformers from an early age. They showed impaired synaptic plasticity, glial cell activation, and cognitive decline, followed by the accumulation of Aβ plaques and tau hyperphosphorylation. In addition, the protein expression of hypoxia-inducible factor (HIF)-1α was increased, and gene expression of HIF-3α was decreased in NL-P-F mice. HIF dysregulation due to the production of soluble toxic conformers may be involved in AD pathology in NL-P-F mice. This study could reveal the role of a highly toxic Aβ on AD pathogenesis, thereby contributing to the development of a novel therapeutic strategy targeting the toxic conformer. MDPI 2022-10-31 /pmc/articles/PMC9654501/ /pubmed/36362046 http://dx.doi.org/10.3390/ijms232113259 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Maki, Takahito
Sawahata, Masahito
Akutsu, Ichiro
Amaike, Shohei
Hiramatsu, Genki
Uta, Daisuke
Izuo, Naotaka
Shimizu, Takahiko
Irie, Kazuhiro
Kume, Toshiaki
APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer’s Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression
title APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer’s Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression
title_full APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer’s Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression
title_fullStr APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer’s Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression
title_full_unstemmed APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer’s Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression
title_short APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer’s Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression
title_sort app knock-in mice produce e22p-aβ exhibiting an alzheimer’s disease-like phenotype with dysregulation of hypoxia-inducible factor expression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654501/
https://www.ncbi.nlm.nih.gov/pubmed/36362046
http://dx.doi.org/10.3390/ijms232113259
work_keys_str_mv AT makitakahito appknockinmiceproducee22pabexhibitinganalzheimersdiseaselikephenotypewithdysregulationofhypoxiainduciblefactorexpression
AT sawahatamasahito appknockinmiceproducee22pabexhibitinganalzheimersdiseaselikephenotypewithdysregulationofhypoxiainduciblefactorexpression
AT akutsuichiro appknockinmiceproducee22pabexhibitinganalzheimersdiseaselikephenotypewithdysregulationofhypoxiainduciblefactorexpression
AT amaikeshohei appknockinmiceproducee22pabexhibitinganalzheimersdiseaselikephenotypewithdysregulationofhypoxiainduciblefactorexpression
AT hiramatsugenki appknockinmiceproducee22pabexhibitinganalzheimersdiseaselikephenotypewithdysregulationofhypoxiainduciblefactorexpression
AT utadaisuke appknockinmiceproducee22pabexhibitinganalzheimersdiseaselikephenotypewithdysregulationofhypoxiainduciblefactorexpression
AT izuonaotaka appknockinmiceproducee22pabexhibitinganalzheimersdiseaselikephenotypewithdysregulationofhypoxiainduciblefactorexpression
AT shimizutakahiko appknockinmiceproducee22pabexhibitinganalzheimersdiseaselikephenotypewithdysregulationofhypoxiainduciblefactorexpression
AT iriekazuhiro appknockinmiceproducee22pabexhibitinganalzheimersdiseaselikephenotypewithdysregulationofhypoxiainduciblefactorexpression
AT kumetoshiaki appknockinmiceproducee22pabexhibitinganalzheimersdiseaselikephenotypewithdysregulationofhypoxiainduciblefactorexpression